02/14/2025
11:26 AM | EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SCHEDULE 13G/A | |
01/29/2025
7:02 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
5:35 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
5:40 AM | Hookipa Pharma (Filer)
| Form DEFA14A | |
01/02/2025
5:00 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
5:05 AM | Hookipa Pharma (Filer)
| Form DEFA14A | |
11/14/2024
5:07 PM | EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
08/30/2024
7:04 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:15 PM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
4:27 PM | Hookipa Pharma (Filer)
| Form 424B5 | |
08/02/2024
5:38 PM | Hookipa Pharma (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for HOOK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter. |
07/24/2024
3:17 PM | Hookipa Pharma (Issuer)
Peters Malte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:18 PM | Coelho Mary Theresa (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:15 PM | Cassidy Sean A (Reporting)
Hookipa Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2024
3:16 PM | Cassidy Sean A (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
6:00 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
5:51 PM | Artal International S.C.A. (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G | |
06/14/2024
5:52 PM | BAKER BROS. ADVISORS LP (Filed by)
Hookipa Pharma (Subject)
| Form SC 13D | |
06/04/2024
3:15 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:25 PM | EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G | |
05/23/2024
4:05 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:03 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:04 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:10 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Necina Roman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Orlinger Klaus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:19 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
